AI & RoboticsNews

Physna raises $20 million for AI that analyzes and digitizes 3D objects

Physna, a Cincinnati, Ohio-based startup developing an AI-powered 3D modeling platform for industrial engineering, today announced that it raised $20 million. The company says the funds will be used to grow its team and increase development as new customers sign on. It’s often difficult to search using the 3D model of a physical part, such as a CAD model or a 3D scan — especially when the part…
Read more
AI & RoboticsNews

Cloud data analytics service Phocas raises $34 million to grow AI, global footprint

Phocas Software‘s cloud data analytics tools might be best known in Australia, where they’re used by Thermo Fisher Scientific, Fiskars Royal Doulton, and Burson Automotive to streamline employee access to key financial data, but the company is planning to become more aggressive globally in 2021. Today, Phocas announced that it raised $34 million to bolster its AI capabilities and reach new…
Read more
AI & RoboticsNews

AI holds the key to even better AI

For all the talk about how artificial intelligence technology is transforming entire industries, the reality is that most businesses struggle to obtain real value from AI. 65% of organizations that have invested in AI in recent years haven’t yet seen any tangible gains…
AI & RoboticsNews

Researchers propose AI system that summarizes historical texts

Summarizing historical text can help people gather, organize, and share knowledge, but cultural and linguistic changes and the sheer volume of archives can make interpreting historical text challenging even for experts. Researchers at the University of Sheffield, Beihang University, and the Open University in the U.K. recently attempted to tackle this problem using AI and machine learning…
Read more
AI & RoboticsNews

Ukko raises $40 million to address food allergies with AI

Ukko, a 30-employee biotech company using AI to investigate solutions for food allergies and sensitivities, today raised $40 million in a series B round led by Bayer’s Leaps by Bayer. Ukko says the new funding will allow it to enter clinical trials with an investigational therapeutic for peanut allergies while accelerating development of its synthetic gluten for people with celiac and other…
Read more